Videos

Krazati and Erbitux Combo Benefits KRAS G12C+ Metastatic Colorectal Cancer

February 20th 2025, 4:00pm

Video

Dr. Nataliya Uboha explained the benefit of treatment with Krazati combined with Erbitux in KRAS G12C–mutant metastatic colorectal cancer.

Explaining PROs From the TiNivo-2 Study in Advanced Renal Cell Carcinoma

February 19th 2025, 5:00pm

Video

Dr. Katy Beckermann discusses how a Fotivda and Opdivo combination for renal cell carcinoma compared with Fotivda alone based on patient feedback.

An Expert Breaks Down the Effect of Diabetes on Urothelial Cancer Treatment

February 18th 2025, 5:00pm

Video

Dr. Petros Grivas discusses what precautions should be considered when treating patients with advanced urothelial carcinoma who have diabetes.

Understanding the Distinction Between HER2-Low and HER2-Ultralow Breast Cancer

February 17th 2025, 10:00pm

Video

Dr. Debu Tripathy discussed the importance of understanding the distinctions between HER2-low and HER2-ultralow breast cancer.

An Expert Explains The Risk and Outcomes of Primary Urothelial Cancer Treatment

February 17th 2025, 5:00pm

Video

Primary urothelial cancer has variable histologies, making its treatment complex, leading to varied outcomes with high rates of recurrence in patients.

Treatment Intensification Adoption Differences Across Prostate Cancer

February 16th 2025, 7:00pm

Video

There are differences in prostate cancer treatment intensification adoption between academic and nonacademic physicians.

Understanding How One Must Interpret PSA Levels in Prostate Cancer

February 14th 2025, 10:00pm

Video

Dr. Barry W. Goy explains how to interpret PSA levels after prostate cancer treatment and how to manage recurrence based on disease progression.

An Expert Explains Updated Data For Patients With GU Cancers

February 13th 2025, 9:35pm

Video

Dr. Guru P Sonpavde discusses updated data from studies like EV-302 and CheckMate 274 for patients with urothelial cancer at the 2025 ASCO GU meeting.

Breaking Down the Implications of Calquence Combination Therapy in MCL

February 13th 2025, 2:00pm

Video

Dr. Tycel Phillips discusses the implications of the FDA approval of Calquence plus bendamustine and Rituxan in previously untreated mantle cell lymphoma.

Empowering Patients and Advocating For Yourself After Cervical Cancer

February 12th 2025, 5:00pm

Video

Dr. Ritu Salani discusses how patients with cervical cancer can advocate for their health and collaborate with their medical team to ensure the best care.